0001178913-17-000262.txt : 20170201 0001178913-17-000262.hdr.sgml : 20170201 20170201171253 ACCESSION NUMBER: 0001178913-17-000262 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170201 DATE AS OF CHANGE: 20170201 EFFECTIVENESS DATE: 20170201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Advanced Inhalation Therapies (AIT) Ltd. CENTRAL INDEX KEY: 0001602294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-279841 FILM NUMBER: 17565786 BUSINESS ADDRESS: STREET 1: 2 DERECH MEIR WEISGAL STREET 2: SCIENCE PARK CITY: REHOVOT STATE: L3 ZIP: 9632605 BUSINESS PHONE: 972 8 6843313 MAIL ADDRESS: STREET 1: 2 DERECH MEIR WEISGAL STREET 2: SCIENCE PARK CITY: REHOVOT STATE: L3 ZIP: 9632605 D 1 primary_doc.xml X0707 D LIVE 0001602294 Advanced Inhalation Therapies (AIT) Ltd. 2 DERECH MEIR WEISGAL REHOVOT L3 ISRAEL 763205 +972.8.684.3313 ISRAEL None None Corporation true Amir Avniel 2 Derech Meir Weisgal Rehovot L3 ISRAEL 763205 Executive Officer Director President, Chief Executive Officer and Director Ron Bentsur 2 Derech Meir Weisgal Rehovot L3 ISRAEL 763205 Director Yossef Av-Gay 2 Derech Meir Weisgal Rehovot L3 ISRAEL 763205 Director Racheli Vizman 2 Derech Meir Weisgal Rehovot L3 ISRAEL 763205 Executive Officer David Grossman 2 Derech Meir Weisgal Rehovot L3 ISRAEL 763205 Director Ari Raved 2 Derech Meir Weisgal Rehovot L3 ISRAEL 763205 Director Jerome B. Zeldis 2 Derech Meir Weisgal Rehovot L3 ISRAEL 763205 Director Steven A. Lisi 2 Derech Meir Weisgal Rehovot L3 ISRAEL 763205 Director Biotechnology Decline to Disclose 06b false 2017-01-13 false true true true false 0 Ladenburg Thalmann & Co. Inc. 505 None None 570 LEXINGTON AVE., 11TH FLOOR NEW YORK NY NEW YORK 10022 CA CALIFORNIA IL ILLINOIS NY NEW YORK false 10209468 10209468 0 false 39 604214 0 150000 false Advanced Inhalation Therapies (AIT) Ltd. /s/ Amir Avniel Amir Avniel President and Chief Executive Officer 2017-02-01